• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绿茶儿茶素对脂肪肝疾病的有益作用:一项系统评价

Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review.

作者信息

Abunofal Omar, Mohan Chandra

机构信息

Department of Biomedical Engineering, University of Houston, 3517 Cullen Blvd, Room 2004, Houston, TX 77204, USA.

出版信息

Medicines (Basel). 2022 Mar 1;9(3):20. doi: 10.3390/medicines9030020.

DOI:10.3390/medicines9030020
PMID:35323719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8949532/
Abstract

Epigallocatechin-3-gallate (EGCG) is a polyphenol green tea catechin with potential health benefits and therapeutic effects in non-alcoholic fatty liver disease (NAFLD), a common liver disorder that adversely affects liver function and lipid metabolism. This systematic review surveyed the effects of EGCG or green tea extract (GTE) on NAFLD reported in studies involving rodent models or humans with a focus on clinicopathologic outcomes, lipid and carbohydrate metabolism, and inflammatory, oxidative stress, and liver injury markers. Articles involving clinical efficacy of EGCG/GTE on human subjects and rodent models were gathered by searching the PUBMED database and by referencing additional articles identified from other literature reviews. EGCG or GTE supplementation reduced body weight, adipose tissue deposits, and food intake. Mechanistically, the majority of these studies confirmed that EGCG or GTE supplementation plays a significant role in regulating lipid and glucose metabolism and expression of genes involved in lipid synthesis. Importantly, EGCG and GTE supplementation were shown to have beneficial effects on oxidative stress-related pathways that activate pro-inflammatory responses, leading to liver damage. In conclusion, green tea catechins are a potentially useful treatment option for NAFLD. More research is required to determine the ideal dosage, treatment duration, and most effective delivery method of EGCG or GTE, and to provide more definitive conclusions by performing large, randomized clinical trials.

摘要

表没食子儿茶素-3-没食子酸酯(EGCG)是一种多酚类绿茶儿茶素,对非酒精性脂肪性肝病(NAFLD)具有潜在的健康益处和治疗作用。NAFLD是一种常见的肝脏疾病,会对肝功能和脂质代谢产生不利影响。本系统评价调查了EGCG或绿茶提取物(GTE)对涉及啮齿动物模型或人类的研究中报告的NAFLD的影响,重点关注临床病理结果、脂质和碳水化合物代谢以及炎症、氧化应激和肝损伤标志物。通过搜索PUBMED数据库并参考从其他文献综述中确定的其他文章,收集了涉及EGCG/GTE对人类受试者和啮齿动物模型临床疗效的文章。补充EGCG或GTE可降低体重、脂肪组织沉积和食物摄入量。从机制上讲,这些研究中的大多数证实,补充EGCG或GTE在调节脂质和葡萄糖代谢以及参与脂质合成的基因表达方面发挥着重要作用。重要的是,EGCG和GTE补充剂对激活促炎反应导致肝损伤的氧化应激相关途径具有有益作用。总之,绿茶儿茶素是NAFLD一种潜在有用的治疗选择。需要更多的研究来确定EGCG或GTE的理想剂量、治疗持续时间和最有效的给药方法,并通过进行大型随机临床试验提供更明确的结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/bd73cc966190/medicines-09-00020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/8b38e257f201/medicines-09-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/38b1e243ec37/medicines-09-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/95a9b63ba103/medicines-09-00020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/bd73cc966190/medicines-09-00020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/8b38e257f201/medicines-09-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/38b1e243ec37/medicines-09-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/95a9b63ba103/medicines-09-00020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8949532/bd73cc966190/medicines-09-00020-g004.jpg

相似文献

1
Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review.绿茶儿茶素对脂肪肝疾病的有益作用:一项系统评价
Medicines (Basel). 2022 Mar 1;9(3):20. doi: 10.3390/medicines9030020.
2
Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG).富含表没食子儿茶素(EGC)和表没食子儿茶素没食子酸酯(EGCG)的绿茶提取物的制备及其抗氧化活性
J Agric Food Chem. 2009 Feb 25;57(4):1349-53. doi: 10.1021/jf803143n.
3
Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.没食子儿茶素没食子酸酯可预防非酒精性脂肪性肝炎,效果类似于绿茶提取物,而对肠道微生物群有不同的影响。
J Nutr Biochem. 2020 Oct;84:108455. doi: 10.1016/j.jnutbio.2020.108455. Epub 2020 Jun 20.
4
EGCG and catechin relative to green tea extract differentially modulate the gut microbial metabolome and liver metabolome to prevent obesity in mice fed a high-fat diet.EGCG 和儿茶素相对于绿茶提取物可差异化调节高脂肪饮食喂养的肥胖小鼠的肠道微生物代谢组和肝脏代谢组。
J Nutr Biochem. 2022 Nov;109:109094. doi: 10.1016/j.jnutbio.2022.109094. Epub 2022 Jun 29.
5
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.美国药典(USP)对绿茶提取物肝毒性的全面综述。
Toxicol Rep. 2020 Feb 15;7:386-402. doi: 10.1016/j.toxrep.2020.02.008. eCollection 2020.
6
Effects of EGCG content in green tea extract on pharmacokinetics, oxidative status and expression of inflammatory and apoptotic genes in the rat ocular tissues.绿茶提取物中表没食子儿茶素没食子酸酯(EGCG)含量对大鼠眼组织药代动力学、氧化状态以及炎症和凋亡相关基因表达的影响
J Nutr Biochem. 2015 Nov;26(11):1357-67. doi: 10.1016/j.jnutbio.2015.07.001. Epub 2015 Jul 26.
7
Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome.绿茶提取物中含有的表没食子儿茶素没食子酸酯可调节唐氏综合征患者的面部发育。
Sci Rep. 2021 Feb 25;11(1):4715. doi: 10.1038/s41598-021-83757-1.
8
Lipid rafts mediate epigallocatechin-3-gallate- and green tea extract-dependent viability of human colon adenocarcinoma COLO 205 cells; clusterin affects lipid rafts-associated signaling pathways.脂筏介导表没食子儿茶素没食子酸酯和绿茶提取物依赖的人结肠腺癌 COLO 205 细胞活力;簇蛋白影响脂筏相关信号通路。
J Physiol Pharmacol. 2011 Aug;62(4):449-59.
9
Protective effect of green tea and epigallocatechin-3-gallate in a LPS-induced systemic inflammation model.绿茶和表没食子儿茶素没食子酸酯在脂多糖诱导的全身炎症模型中的保护作用。
J Nutr Biochem. 2022 Mar;101:108920. doi: 10.1016/j.jnutbio.2021.108920. Epub 2021 Dec 4.
10
Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.绿茶提取物和(-)-表没食子儿茶素没食子酸酯对纳多洛尔在大鼠体内药代动力学的影响。
Phytomedicine. 2013 Nov 15;20(14):1247-50. doi: 10.1016/j.phymed.2013.07.003. Epub 2013 Aug 3.

引用本文的文献

1
Efficacy of dietary polyphenol supplement in patients with non-alcoholic fatty liver disease: a network meta-analysis.膳食多酚补充剂对非酒精性脂肪性肝病患者的疗效:一项网状Meta分析。
Front Nutr. 2025 May 9;12:1582861. doi: 10.3389/fnut.2025.1582861. eCollection 2025.
2
Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review.评估基于生物活性物质的干预措施对患有代谢功能障碍相关脂肪性肝病(MASLD)的成年人的影响:一项系统综述的结果
Nutrients. 2025 Jan 26;17(3):453. doi: 10.3390/nu17030453.
3
The potential protective effect of Camellia Sinensis in mitigating monosodium glutamate-induced neurotoxicity: biochemical and histological study in male albino rats.

本文引用的文献

1
Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization.没食子酸表没食子儿茶素酯通过调节肝功能、脂质谱和巨噬细胞极化来抑制非酒精性脂肪肝。
Nutrients. 2021 Feb 11;13(2):599. doi: 10.3390/nu13020599.
2
The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metabolic Health in Overweight, Recreationally Active Individuals.脱咖啡因绿茶提取物对超重、有规律运动的个体的脂肪氧化、身体成分和心肺代谢健康的影响。
Nutrients. 2021 Feb 26;13(3):764. doi: 10.3390/nu13030764.
3
Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet.
茶在减轻谷氨酸单钠诱导的神经毒性中的潜在保护作用:雄性白化大鼠的生化和组织学研究。
Metab Brain Dis. 2024 Jun;39(5):953-966. doi: 10.1007/s11011-024-01365-0. Epub 2024 Jun 13.
4
Complementary and alternative medicines and liver disease.补充和替代医学与肝脏疾病。
Hepatol Commun. 2024 Apr 3;8(4). doi: 10.1097/HC9.0000000000000417. eCollection 2024 Apr 1.
5
Protective effects of hepatic diseases by bioactive phytochemicals in A review.生物活性植物化学物质对肝脏疾病的保护作用综述
Heliyon. 2024 Feb 20;10(5):e26562. doi: 10.1016/j.heliyon.2024.e26562. eCollection 2024 Mar 15.
6
Medicinal herbs and their metabolites with biological potential to protect and combat liver toxicity and its disorders: A review.具有保护和对抗肝脏毒性及其疾病生物潜力的药草及其代谢产物:综述
Heliyon. 2024 Feb 1;10(3):e25340. doi: 10.1016/j.heliyon.2024.e25340. eCollection 2024 Feb 15.
7
Epigallocatechin-3-Gallate, an Active Green Tea Component to Support Anti-VEGFA Therapy in Wet Age-Related Macular Degeneration.没食子酸表没食子儿茶素酯,一种支持湿性年龄相关性黄斑变性抗 VEGF 治疗的绿茶有效成分。
Nutrients. 2023 Jul 28;15(15):3358. doi: 10.3390/nu15153358.
8
Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease.天然化合物治疗非酒精性脂肪肝病的分子机制途径。
Molecules. 2023 Jul 25;28(15):5645. doi: 10.3390/molecules28155645.
9
Green Tea Catechins Attenuate Neurodegenerative Diseases and Cognitive Deficits.绿茶儿茶素可减轻神经退行性疾病和认知障碍。
Molecules. 2022 Nov 6;27(21):7604. doi: 10.3390/molecules27217604.
绿茶多酚表没食子儿茶素没食子酸酯可缓解高脂饮食诱导的非酒精性脂肪肝病并改善肠道免疫。
Food Funct. 2020 Nov 18;11(11):9924-9935. doi: 10.1039/d0fo02152k.
4
Epigallocatechin Gallate Protects Mice against Methionine-Choline-Deficient-Diet-Induced Nonalcoholic Steatohepatitis by Improving Gut Microbiota To Attenuate Hepatic Injury and Regulate Metabolism.表没食子儿茶素没食子酸酯通过改善肠道微生物群以减轻肝损伤和调节代谢,保护小鼠免受蛋氨酸-胆碱缺乏饮食诱导的非酒精性脂肪性肝炎。
ACS Omega. 2020 Aug 12;5(33):20800-20809. doi: 10.1021/acsomega.0c01689. eCollection 2020 Aug 25.
5
Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies.沿肠-肝轴的绿茶儿茶素对非酒精性脂肪性肝病的抗炎活性:临床前和人体研究中得到的启示。
J Nutr Biochem. 2020 Nov;85:108478. doi: 10.1016/j.jnutbio.2020.108478. Epub 2020 Aug 12.
6
The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high-fat diet-fed obese rats.表没食子儿茶素没食子酸酯通过改善高脂肪饮食喂养肥胖大鼠的脂质代谢、减少炎症和氧化应激来延长其寿命。
Aging Cell. 2020 Sep;19(9):e13199. doi: 10.1111/acel.13199. Epub 2020 Jul 30.
7
Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.没食子儿茶素没食子酸酯可预防非酒精性脂肪性肝炎,效果类似于绿茶提取物,而对肠道微生物群有不同的影响。
J Nutr Biochem. 2020 Oct;84:108455. doi: 10.1016/j.jnutbio.2020.108455. Epub 2020 Jun 20.
8
Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.表没食子儿茶素没食子酸酯通过抑制Toll样受体4信号通路抑制炎症反应并减轻高脂饮食大鼠肝脏中的胰岛素抵抗。
J Oleo Sci. 2020 May 2;69(5):479-486. doi: 10.5650/jos.ess19303. Epub 2020 Apr 13.
9
Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials.绿茶或儿茶素对健康人群和非酒精性脂肪性肝病患者肝酶的影响:系统评价和随机临床试验荟萃分析。
Phytother Res. 2020 Jul;34(7):1587-1598. doi: 10.1002/ptr.6637. Epub 2020 Feb 18.
10
Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis.非酒精性脂肪性肝病和酒精性肝炎的新兴医学疗法。
Transl Gastroenterol Hepatol. 2019 Jul 19;4:53. doi: 10.21037/tgh.2019.06.06. eCollection 2019.